Health Catalyst, Inc.
HCAT
$1.10
-$0.12-9.50%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -2.15% | -5.45% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.15% | -5.45% | |||
| Cost of Revenue | -5.62% | -11.50% | |||
| Gross Profit | 1.17% | 1.20% | |||
| SG&A Expenses | -13.97% | -9.49% | |||
| Depreciation & Amortization | 2.12% | -0.55% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.26% | -9.10% | |||
| Operating Income | 58.15% | 34.38% | |||
| Income Before Tax | -308.54% | 45.75% | |||
| Income Tax Expenses | 824.39% | -49.38% | |||
| Earnings from Continuing Operations | -309.49% | 45.75% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -309.49% | 45.75% | |||
| EBIT | 58.15% | 34.38% | |||
| EBITDA | 256.56% | 188.98% | |||
| EPS Basic | -305.86% | 46.32% | |||
| Normalized Basic EPS | 37.53% | 21.11% | |||
| EPS Diluted | -305.86% | 46.32% | |||
| Normalized Diluted EPS | 37.53% | 21.11% | |||
| Average Basic Shares Outstanding | 0.88% | 1.08% | |||
| Average Diluted Shares Outstanding | 0.88% | 1.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||